Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies

Journal

  • Annals of Hematology

    Annals of Hematology 93 (1), 169-171, 2013-04-24

    Springer Science and Business Media LLC

Citations (2)*help

See more

Report a problem

Back to top